Position in BMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$32,785
-$1,360 QoQ
Shares Held
569
+1.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#970
of 1,032 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Darwin Wealth Management, LLC holds $3,263,088 across 14 Drug Manufacturers - General names. BMY ranks #5 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
7,977 | $2,025,918 | |
| 2 | ABBV |
AbbVie Inc.
|
1,924 | $484,155 | |
| 3 | LLY |
ELI LILLY & Co
|
342 | $410,205 | |
| 4 | AMGN |
Amgen Inc
|
525 | $190,113 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
569 | $32,785 | |
| 6 | PFE |
Pfizer Inc
|
1,354 | $32,604 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
216 | $27,289 | |
| 8 | GSK |
GSK plc
|
432 | $22,645 |
All Filings in BMY
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,785 | 569 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $34,145 | 563 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $30,044 | 557 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $24,850 | 551 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $25,181 | 544 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $34,337 | 563 | Shares | Sole | 2025-08-18 | |
| 2024-12-31 | $31,843 | 563 | Shares | Sole | 2025-09-02 | |
| 2024-09-30 | $28,870 | 558 | Shares | Sole | 2024-11-08 | |
| 2020-06-30 | $289,119 | 4,917 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $3,142,398 | 56,376 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||